Get caught up quickly on the top news and calls moving stocks with these Top Fives, as compiled by the editors of The Fly.
1. STOCK NEWS:
- FedEx (FDX) reported lower than expected adjusted earnings for Q1 [more]
- Adobe (ADBE) reported upbeat Q3 earnings and revenue [more]
- Gilead (GILD) said that Veklury reduced COVID-19 related hospital risk by 87% in a study of those at high-risk [more]
- Pfizer (PFE) and BioNTech (BNTX) will supply an additional 500M COVID-19 vaccine doses to poor countries [more]
- Stitch Fix (SFIX) reported a surprise profit in Q4 [more]
2. WALL STREET CALLS:
- Xponential Fitness (XPOF) double upgraded to Strong Buy at Raymond James [more]
- SoFi (SOFI) higher as Jefferies says Buy, sees over 50% upside potential [more]
- Evercore starts SunPower (SPWR) at Outperform, sees 26% upside potential [more]
- Ambarella (AMBA) upgraded to Overweight from Sector Weight at KeyBanc [more]
- FibroGen (FGEN) downgraded to Sell from Neutral at Goldman Sachs [more]
3. AROUND THE WEB:
- Amazon (AMZN) plans to open department stores to sell its clothing brands, WSJ reports [more]
- More than 5M pre-orders have been made for Apple's (AAPL) iPhone 13 range in China, SCMP says [more]
- EDF (ECIFF) is in early talks to acquire GE's (GE) nuclear turbines unit, Bloomberg says [more]
- Biogen (BIIB) is weighing layoffs amid a bleak Aduhelm launch, STAT reports [more]
- McDonald's (MCD) will significantly cut its use of plastic in toys by 2025, Reuters reports [more]
4. MOVERS:
- Dynavax (DVAX) increases after reporting “positive” data from its Phase 2/3 clinical trial studying the company’s protein-based COVID-19 vaccine candidate, SCB-2019 [more]
- Teck Resources (TECK) rises in New York after BMO Capital analyst Jackie Przbylowski upgraded the stock to Outperform from Market Perform with a price target of C$44, up from C$40 [more]
- Gaotu Techedu (GOTU) higher in New York after announcing quarterly results [more]
- Workhorse Group (WKHS) lower after deciding to suspend the deliveries of C-1000 vehicles and recalling 41 vehicles it had already delivered [more]
- Incyte (INCY) falls after the FDA approved the company’s Opzeluara cream in Atopic Dermatitis treatment, whose label will carry the FDA’s JAK-class warning [more]
5. EARNINGS/GUIDANCE:
- General Mills (GIS) reported upbeat Q1 results [more]
- InnovAge (INNV) reported better than expected Q4 revenue [more]
- BioDelivery Sciences (BDSI) provided Q3 revenue guidance [more]
- Nexters (GDEV) reported year-over-year Q2 revenue growth [more]
- Akari Therapeutics (AKTX) reported Q2 results [more]
INDEXES:
Near 1 pm ET, the Dow was up 389.85, or 1.15%, to 34,309.69, the Nasdaq was up 125.32, or 0.85%, to 14,871.72, and the S&P 500 was up 44.54, or 1.02%, to 4,398.73.